Home › T-Cell Lymphoma › Massachusetts › Boston
T-Cell Lymphoma clinical trials in Boston, MA
8 studies for T-Cell Lymphoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Massachusetts General Hospital, Boston
A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RecruitingPhase 1/2
- Massachusetts General Hospital, Boston
Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
RecruitingPhase 2
- Dana Farber Cancer Institute, Boston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Massachusetts General Hospital (Data Collection Only), Boston
- Dana Farber Cancer Institute (Data Collection Only), Boston
MB-105 in Patients With CD5 Positive T-cell Lymphoma
RecruitingPhase 2
- Massachusetts General Hospital, Boston
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Dana-Farber Cancer Institute, Boston
T-Cell Lymphoma trials in other cities
- New York City, NY12 studies
- Baldwin Park, CA10 studies
- Houston, TX9 studies
- Philadelphia, PA9 studies
- Atlanta, GA8 studies
- Chicago, IL6 studies
- Columbus, OH6 studies
- Rochester, MN6 studies
- Seattle, WA6 studies
- New Haven, CT5 studies
- Miami, FL5 studies
- Scottsdale, AZ4 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.